Rare cancer care under the microscope: what 2,000+ patients teach us
NCT ID NCT03977818
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study looked back at the medical records of over 2,100 adults with advanced soft tissue sarcoma to see what treatments they actually received and how long they lived. Researchers focused on how often patients got chemotherapy, surgery for their tumors, or drugs not officially approved for their cancer. The goal was to learn from real-world care to improve future treatment and research for this rare cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Léon Bérard, Comprehensive Cancer Center
Lyon, France
-
Institut Bergonié, Comprehensive Cancer Center
Bordeaux, France
-
Institut Gustave Roussy, Comprehensive Cancer Center
Villejuif, France
Conditions
Explore the condition pages connected to this study.